← Leaderboards
Harold L Moses
Vanderbilt University
$33,288,478
Attributed
$38,140,110
Total exposure
29
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$65,028,453 · 32
By mechanism
U54$20,280,049 · 11
P30$15,907,085 · 9
U09$12,347,424 · 1
R01$10,977,383 · 2
U01$3,934,500 · 2
T32$831,262 · 1
Top collaborators
- Lynn M Matrisian20 shared
- Valerie Marie Weaver10 shared
- Ann Richmond9 shared
- Raghu Kalluri5 shared
- David L Gorden3 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Robert A Kesterson$10,120,274
- Mark A Magnuson$75,018,827
- Magaly Martinez-Ferrer$909,694
- David L Gorden$1,457,565
- Ty William Abel$838,243
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResearch PersonnelCancer Health DisparityProgramsRecruitment ActivityOncologyBaseAnticancer ResearchNeoplasm /CancerFacultyBiomedical FacilityInstitutionCollaborationsGrantResourcesNational Cancer InstituteCellsTumorCancer CenterMammary GlandMonitorUniversitiesMedical SchoolsMentors
Grant awards (152)
Administrative Core$122,356
U54 · FY2020 · CA · contact PI
Administrative Core$118,631
U54 · FY2019 · CA · contact PI
Administrative Core$122,356
U54 · FY2018 · CA · contact PI
Precision Smoking Treatment among Disabled Persons in the Southern Community Cohort Study$104,015
U54 · FY2018 · CA · contact PI
Administrative Core$11,558
U54 · FY2018 · CA · contact PI
MMC, VICC, & TSU: PARTNERS IN ELIMINATING CANCER DISPARITIES (2 of 3)$1,233,813
U54 · FY2017 · CA · contact PI
Administrative Core$122,356
U54 · FY2017 · CA · contact PI
MMC, VICC, & TSU: PARTNERS IN ELIMINATING CANCER DISPARITIES (2 of 3)$1,225,501
U54 · FY2016 · CA · contact PI
Administrative Core$122,355
U54 · FY2016 · CA · contact PI
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 2 of 3)$664,819
U54 · FY2015 · CA · contact PI
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 2 of 3)$558,241
U54 · FY2015 · CA · contact PI
TGF-beta Suppression and Promotion of Mammary Carcinomas$455,112
R01 · FY2015 · CA · contact PI
Administration - Recruitment$208,315
U54 · FY2015 · CA · contact PI
Future Full and Pilot Projects$202,356
U54 · FY2015 · CA · contact PI
Training$201,657
U54 · FY2015 · CA · contact PI
Administration Core$106,833
U54 · FY2015 · CA · contact PI
Planning and Evaluation Core$26,303
U54 · FY2015 · CA · contact PI
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 2 of 3)$1,269,768
U54 · FY2014 · CA · contact PI
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC$562,648
U01 · FY2014 · CA
TGF-beta Suppression and Promotion of Mammary Carcinomas$439,217
R01 · FY2014 · CA · contact PI
Administration - Recruitment$210,387
U54 · FY2014 · CA · contact PI
Training$203,927
U54 · FY2014 · CA · contact PI
Future Full and Pilot Projects$186,144
U54 · FY2014 · CA · contact PI
Administration Core$112,790
U54 · FY2014 · CA · contact PI
Planning and Evaluation Core$34,344
U54 · FY2014 · CA · contact PI
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 2 of 3)$800,339
U54 · FY2013 · CA · contact PI
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC$586,932
U01 · FY2013 · CA
TGF-beta in Mammary Development and Tumorigenesis$428,812
R01 · FY2013 · CA · contact PI
TGF-beta Suppression and Promotion of Mammary Carcinomas$423,505
R01 · FY2013 · CA · contact PI
Molecular Determinants of Tumor Progression in A Steatolic Liver Microenvironment$258,797
U01 · FY2013 · CA
Training$188,551
U54 · FY2013 · CA · contact PI
Administration Core$101,528
U54 · FY2013 · CA · contact PI
Planning and Evaluation Core$25,586
U54 · FY2013 · CA · contact PI
Administration - Recruitment$2,245
U54 · FY2013 · CA · contact PI
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 2 of 3)$1,044,393
U54 · FY2012 · CA · contact PI
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC$647,718
U01 · FY2012 · CA
TGF-beta in Mammary Development and Tumorigenesis$458,297
R01 · FY2012 · CA · contact PI
TGF-beta Suppression and Promotion of Mammary Carcinomas$448,305
R01 · FY2012 · CA · contact PI
Molecular Determinants of Tumor Progression in A Steatolic Liver Microenvironment$224,069
U01 · FY2012 · CA
Training$201,660
U54 · FY2012 · CA · contact PI
Administration Core$109,486
U54 · FY2012 · CA · contact PI
Planning and Evaluation Core$27,913
U54 · FY2012 · CA · contact PI
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 2 of 3)$1,066,141
U54 · FY2011 · CA · contact PI
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC$648,725
U01 · FY2011 · CA
TGF-beta Suppression and Promotion of Mammary Carcinomas$461,448
R01 · FY2011 · CA · contact PI
TGF-beta in Mammary Development and Tumorigenesis$460,474
R01 · FY2011 · CA · contact PI
Molecular Determinants of Tumor Progression in A Steatolic Liver Microenvironment$299,787
U01 · FY2011 · CA
Training$201,660
U54 · FY2011 · CA · contact PI
Administration Core$110,405
U54 · FY2011 · CA · contact PI
Planning and Evaluation Core$28,472
U54 · FY2011 · CA · contact PI
MMC and VICC: Partners in Eliminating Cancer Disparities$715,197
U54 · FY2010 · CA · contact PI
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC$705,824
U01 · FY2010 · CA
Developmental Funds$695,853
U54 · FY2010 · CA · contact PI
TGF-beta in Mammary Development and Tumorigenesis$477,024
R01 · FY2010 · CA · contact PI
TGF-Beta Suppression and Promotion of Mammary Carcinomas$463,737
R01 · FY2010 · CA · contact PI
Paracrine TGF-Beta Signaling in Breast Cancer Initiation and Progression$211,448
U54 · FY2010 · CA · contact PI
Planning and Evaluation Core$19,344
U54 · FY2010 · CA · contact PI
MMC and VICC: Partners in Eliminating Cancer Disparities$795,807
U54 · FY2009 · CA · contact PI
Developmental Funds$774,945
U54 · FY2009 · CA · contact PI
TGF-beta in Mammary Development and Tumorigenesis$470,000
R01 · FY2009 · CA · contact PI
TGF-Beta Suppression and Promotion of Mammary Carcinomas$454,641
R01 · FY2009 · CA · contact PI
Paracrine TGF-Beta Signaling in Breast Cancer Initiation and Progression$315,928
U54 · FY2009 · CA · contact PI
Planning and Evaluation Core$20,862
U54 · FY2009 · CA · contact PI
MMC and VICC: Partners in Eliminating Cancer Disparities$551,948
U54 · FY2008 · CA · contact PI
Developmental Funds$535,847
U54 · FY2008 · CA · contact PI
TGF-Beta Suppression and Promotion of Mammary Carcinomas$441,398
R01 · FY2008 · CA · contact PI
TRANSGENIC MOUSE/ES CELL SHARED RESOURCE$312,455
P30 · FY2008 · CA · contact PI
Paracrine TGF-Beta Signaling in Breast Cancer Initiation and Progression$221,761
U54 · FY2008 · CA · contact PI
TGF-beta in Mammary Development and Tumorigenesis$38,375
R01 · FY2008 · CA · contact PI
Planning and Evaluation Core$16,101
U54 · FY2008 · CA · contact PI
ASSESSING ANTIBIOTIC THERAPY FOR CPNEUMONIAE IN THE CNS OF MS PATIENTS$94
M01 · FY2008 · RR · contact PI
MMC and VICC: Partners in Eliminating Cancer Disparities$673,410
U54 · FY2007 · CA · contact PI
Developmental Funds$652,758
U54 · FY2007 · CA · contact PI
TGF-beta in Mammary Development and Tumorigenesis$448,879
R01 · FY2007 · CA · contact PI
TGF-Beta Suppression and Promotion of Mammary Carcinomas$436,193
R01 · FY2007 · CA · contact PI
TRANSGENIC MOUSE/ES CELL SHARED RESOURCE$301,965
P30 · FY2007 · CA · contact PI
Paracrine TGF-Beta Signaling in Breast Cancer Initiation and Progression$234,610
U54 · FY2007 · CA · contact PI
Planning and Evaluation Core$20,652
U54 · FY2007 · CA · contact PI
ASSESSING ANTIBIOTIC THERAPY FOR CPNEUMONIAE IN THE CNS OF MS PATIENTS$1,989
M01 · FY2007 · RR · contact PI
MMC and VICC: Partners in Eliminating Cancer Disparities$676,136
U54 · FY2006 · CA · contact PI
TGF-beta in Mammary Development and Tumorigenesis$450,450
R01 · FY2006 · CA · contact PI
TGF-Beta Suppression and Promotion of Mammary Carcinomas$401,834
R01 · FY2006 · CA · contact PI
Developmental Funds$342,064
U54 · FY2006 · CA · contact PI
Paracrine TGF-Beta Signaling in Breast Cancer Initiation and Progression$154,592
U54 · FY2006 · CA · contact PI
Comprehensive MMC/VICC Cancer Research Partnership$110,600
U54 · FY2006 · CA · contact PI
TRANSGENIC MOUSE/ES CELL SHARED RESOURCE$108,284
P30 · FY2006 · CA · contact PI
ASSESSING ANTIBIOTIC THERAPY FOR CPNEUMONIAE IN THE CNS OF MS PATIENTS$11,745
M01 · FY2006 · RR · contact PI
Planning and Evaluation Core$10,768
U54 · FY2006 · CA · contact PI
TGF-beta in Mammary Development and Tumorigenesis$449,527
R01 · FY2005 · CA
Comprehensive MMC/VICC Cancer Research Partnership$252,517
U54 · FY2005 · CA
TRANSGENIC MOUSE/ES CELL SHARED RESOURCE$105,130
P30 · FY2005 · CA
TGF BETA SUPPRESSION AND PROMOTION OF MAMMARY CARCINOMAS$75,917
R01 · FY2005 · CA
Overcoming Colorectal Cancer Disparities$40,000
R13 · FY2005 · CA
ASSESSING ANTIBIOTIC THERAPY FOR CPNEUMONIAE IN THE CNS OF MS PATIENTS$19,343
M01 · FY2005 · RR
TGF-beta in Mammary Development and Tumorigenesis$438,104
R01 · FY2004 · CA
TGF BETA SUPPRESSION AND PROMOTION OF MAMMARY CARCINOMAS$406,223
R01 · FY2004 · CA
DEVELOPMENT$386,900
P30 · FY2004 · CA
PROTOCOL SPECIFIC RESEARCH SUPPORT$290,729
P30 · FY2004 · CA
Comprehensive MMC/VICC Cancer Research Partnership$237,151
U54 · FY2004 · CA
SENIOR LEADERSHIP$236,379
P30 · FY2004 · CA
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$132,548
K23 · FY2004 · RR
TRANSGENIC MOUSE/ES CELL SHARED RESOURCE$102,068
P30 · FY2004 · CA
DATA &SAFETY MONITORING$65,330
P30 · FY2004 · CA
PROGRAM PLANNING &EVALUATION$51,844
P30 · FY2004 · CA
Assessing Antibiotic therapy for C.pneumoniae in the CNS of MS patients$4,952
M01 · FY2004 · RR
NATIONAL CANCER INSTITUTE INITIAL REVIEW GROUP$3,464,000
U09 · FY2003 · CA
CANCER CENTER SUPPORT GRANT$3,221,787
P30 · FY2003 · CA
TGF-beta in Mammary Development and Tumorigenesis$427,013
R01 · FY2003 · CA
TGF BETA SUPPRESSION AND PROMOTION OF MAMMARY CARCINOMAS$396,398
R01 · FY2003 · CA
Comprehensive MMC/VICC Cancer Research Partnership$324,140
U54 · FY2003 · CA
CANCER CENTER SUPPORT GRANT$304,000
P30 · FY2003 · CA
CANCER CENTER SUPPORT GRANT$139,737
P30 · FY2003 · CA
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$133,571
K23 · FY2003 · RR
NATIONAL CANCER INSTITUTE INITIAL REVIEW GROUP$3,348,000
U09 · FY2002 · CA
CANCER CENTER SUPPORT GRANT$2,983,163
P30 · FY2002 · CA
TGF BETA SUPPRESSION AND PROMOTION OF MAMMARY CARCINOMAS$385,886
R01 · FY2002 · CA
Comprehensive MMC/VICC Cancer Research Partnership$303,165
U54 · FY2002 · CA
CANCER CENTER SUPPORT GRANT$284,000
P30 · FY2002 · CA
NATIONAL CANCER INSTITUTE INITIAL REVIEW GROUP$250,000
U09 · FY2002 · CA
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$134,650
K23 · FY2002 · RR
Core--Developmental funds$0
P30 · FY2002 · CA
Core--Developmental funds$0
P30 · FY2002 · CA
Core--Protocol specific research support$0
P30 · FY2002 · CA
Core--Protocol specific research support$0
P30 · FY2002 · CA
NATIONAL CANCER INSTITUTE INITIAL REVIEW GROUP$3,398,000
U09 · FY2001 · CA
CANCER CENTER SUPPORT GRANT$3,036,441
P30 · FY2001 · CA
MULTIDISCIPLINARY BASIC RESEARCH TRAINING IN CANCER$427,421
T32 · FY2001 · CA
TGF BETA SUPPRESSION AND PROMOTION OF MAMMARY CARCINOMAS$375,679
R01 · FY2001 · CA
Comprehensive MMC/VICC Cancer Research Partnership$335,241
U54 · FY2001 · CA
NATIONAL CANCER INSTITUTE INITIAL REVIEW GROUP$250,000
U09 · FY2001 · CA
CANCER CENTER SUPPORT GRANT$200,000
P30 · FY2001 · CA
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$135,602
K23 · FY2001 · RR
Core--Developmental funds$0
P30 · FY2001 · CA
Core--Protocol specific research support$0
P30 · FY2001 · CA
Core--Protocol specific research support$0
P30 · FY2001 · CA
Core--Developmental funds$0
P30 · FY2001 · CA
CANCER CENTER SUPPORT GRANT$3,023,526
P30 · FY2000 · CA
NATIONAL CANCER INSTITUTE INITIAL REVIEW GROUP$1,637,424
U09 · FY2000 · CA
MULTIDISCIPLINARY BASIC RESEARCH TRAINING IN CANCER$403,841
T32 · FY2000 · CA
TGF BETA SUPPRESSION AND PROMOTION OF MAMMARY CARCINOMAS$364,935
R01 · FY2000 · CA
CANCER CENTER SUPPORT GRANT$326,074
P30 · FY2000 · CA
CANCER CENTER SUPPORT GRANT$250,000
P30 · FY2000 · CA
CANCER CENTER SUPPORT GRANT$177,273
P30 · FY2000 · CA
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$136,256
K23 · FY2000 · RR
Core--Protocol specific research support$0
P30 · FY2000 · CA
Core--Developmental funds$0
P30 · FY2000 · CA
Core--Developmental funds$0
P30 · FY2000 · CA
Core--Protocol specific research support$0
P30 · FY2000 · CA
Core--Developmental funds$0
P30 · FY2000 · CA
Core--Protocol specific research support$0
P30 · FY2000 · CA
Core--Protocol specific research support$0
P30 · FY2000 · CA
Core--Developmental funds$0
P30 · FY2000 · CA